Effect of Ranibizumab on Malignant Conjunctival Neoplasia

NCT00456495 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Conjunctival Neoplasms

Interventions

DRUG: ranibizumab

Sponsor

The New York Eye Cancer Center

Collaborators

[object Object]